Elucidating the mechanism by which mutant calreticulin is oncogenic and causes MPN

Speaker: Prof. Ann Mullally, MD, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School,  United States

Date: Thursday, 20th of April 2017, 5:15 pm

Location: Campus FME, Hörsaal Kinderklinik (Haus 10)

Host: Prof. Dr. Thomas Fischer (OvGU, Universitätsklinik für Hämatologie und Onkologie)

Further Information: The Mullally laboratory is a translational oncology laboratory focused on the study of myeloid malignancies, primarily myeloproliferative neoplasms (MPN). The group employs a range of experimental approaches including murine models, functional genomics and proteomics as well as classical cellular and molecular biology.